MS
80
-3
GOOG
69
-10
AMG
43
3
IFF
53
2
CF
53
2
FRT
48
2
EMR
77
-2
DE
36
-2
PNR
74
5
LEN
52
2
NI
73
3
TEL
74
3
DG
12
2
EQT
57
-3
DVA
72
-3
HRL
30
-3
AVY
53
2
BAX
27
-2
AMAT
43
-5
SRE
66
-3
MS
80
-3
GOOG
69
-10
AMG
43
3
IFF
53
2
CF
53
2
FRT
48
2
EMR
77
-2
DE
36
-2
PNR
74
5
LEN
52
2
NI
73
3
TEL
74
3
DG
12
2
EQT
57
-3
DVA
72
-3
HRL
30
-3
AVY
53
2
BAX
27
-2
AMAT
43
-5
SRE
66
-3
Financhill
Back

Perspective Therapeutics Vs. ePlus Industry Stock Comparison

Sell
30

CATX
Perspective Therapeutics

Last Price:
8.92
Seasonality Move:
28.97%
Sell
27

PLUS
ePlus

Last Price:
80.50
Seasonality Move:
20.86%
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $9.93. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
ePlus (PLUS) is a Sell

Is ePlus a Buy, Sell or Hold?

  • The current ePlus [PLUS] share price is $80.03. The Score for PLUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $9.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

PLUS Stock Price Chart

What is ePlus's stock price today?

  • The ePlus share price today is $80.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLUS is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.56 Sell
Relative Strength Index (14 RSI): 28.07 Sell
Chaikin Money Flow: -952055 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.27 - 12.77) Sell
Bollinger Bands (100): (11.25 - 14.33) Sell

PLUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.37 Sell
Relative Strength Index (14 RSI): 28.12 Sell
Chaikin Money Flow: -371573 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.15 - 100.85) Sell
Bollinger Bands (100): (81.19 - 98.29) Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.45 Sell
20-day SMA: 11.83 Sell
50-day SMA: 12.88 Sell
200-day SMA: 12.8 Sell
8-day EMA: 11.13 Sell
20-day EMA: 11.74 Sell
50-day EMA: 12.46 Sell
200-day EMA: 11.73 Sell

PLUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 93.25 Sell
20-day SMA: 94.97 Sell
50-day SMA: 95.27 Sell
200-day SMA: 83.59 Sell
8-day EMA: 92.26 Sell
20-day EMA: 94.28 Sell
50-day EMA: 94.05 Sell
200-day EMA: 84.44 Sell

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and a decrease next year of $0.22 per share.

ePlus Earnings Growth & PLUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ePlus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):